Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Clinical heterogeneity and predictors of outcome in primary autoimmune hemolytic anemia: a GIMEMA study of 308 patients
Wilma Barcellini, Bruno Fattizzo, Anna Zaninoni, et al.
Blood (2014) Vol. 124, Iss. 19, pp. 2930-2936
Open Access | Times Cited: 309

Showing 1-25 of 309 citing articles:

Diagnosis and treatment of autoimmune hemolytic anemia in adults: Recommendations from the First International Consensus Meeting
Ulrich Jäger, Wilma Barcellini, Catherine M. Broome, et al.
Blood Reviews (2019) Vol. 41, pp. 100648-100648
Open Access | Times Cited: 399
Clinical Applications of Hemolytic Markers in the Differential Diagnosis and Management of Hemolytic Anemia
Wilma Barcellini, Bruno Fattizzo
Disease Markers (2015) Vol. 2015, pp. 1-7
Open Access | Times Cited: 255
The diagnosis and management of primary autoimmune haemolytic anaemia
Quentin A. Hill, R. Stamps, Edwin Massey, et al.
British Journal of Haematology (2016) Vol. 176, Iss. 3, pp. 395-411
Open Access | Times Cited: 215
How I treat autoimmune hemolytic anemia
Ronald S. Go, Jeffrey L. Winters, Neil E. Kay
Blood (2017) Vol. 129, Iss. 22, pp. 2971-2979
Open Access | Times Cited: 174
Novel insights into the treatment of complement-mediated hemolytic anemias
Sigbjørn Berentsen, Anita Hill, Quentin A. Hill, et al.
Therapeutic Advances in Hematology (2019) Vol. 10
Open Access | Times Cited: 161
Autoimmune Hemolytic Anemias
Sigbjørn Berentsen, Wilma Barcellini
New England Journal of Medicine (2021) Vol. 385, Iss. 15, pp. 1407-1419
Closed Access | Times Cited: 140
Sutimlimab in patients with cold agglutinin disease: results of the randomized placebo-controlled phase 3 CADENZA trial
Alexander Röth, Sigbjørn Berentsen, Wilma Barcellini, et al.
Blood (2022) Vol. 140, Iss. 9, pp. 980-991
Open Access | Times Cited: 73
New Insights in the Pathogenesis of Autoimmune Hemolytic Anemia
Wilma Barcellini
Transfusion Medicine and Hemotherapy (2015) Vol. 42, Iss. 5, pp. 287-293
Open Access | Times Cited: 153
Clinical spectrum of pyruvate kinase deficiency: data from the Pyruvate Kinase Deficiency Natural History Study
Rachael F. Grace, Paola Bianchi, Eduard J. van Beers, et al.
Blood (2018) Vol. 131, Iss. 20, pp. 2183-2192
Open Access | Times Cited: 147
Autoimmune hemolytic anemia
Anita Hill, Quentin A. Hill
Hematology (2018) Vol. 2018, Iss. 1, pp. 382-389
Open Access | Times Cited: 135
The diagnosis and management of the haematologic manifestations of lupus
Alba Velo-García, Sara Guerreiro Castro, David Isenberg
Journal of Autoimmunity (2016) Vol. 74, pp. 139-160
Open Access | Times Cited: 133
Cold agglutinin disease revisited: a multinational, observational study of 232 patients
Sigbjørn Berentsen, Wilma Barcellini, Shirley D’Sa, et al.
Blood (2020) Vol. 136, Iss. 4, pp. 480-488
Open Access | Times Cited: 123
New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia
Sigbjørn Berentsen
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 120
Warm antibody autoimmune hemolytic anemia
Theodosia A. Kalfa
Hematology (2016) Vol. 2016, Iss. 1, pp. 690-697
Open Access | Times Cited: 116
Warm Autoimmune Hemolytic Anemia
Robert A. Brodsky
New England Journal of Medicine (2019) Vol. 381, Iss. 7, pp. 647-654
Closed Access | Times Cited: 115
Bendamustine plus rituximab for chronic cold agglutinin disease: results of a Nordic prospective multicenter trial
Sigbjørn Berentsen, Ulla Randen, Markku Oksman, et al.
Blood (2017) Vol. 130, Iss. 4, pp. 537-541
Open Access | Times Cited: 113
The Changing Landscape of Autoimmune Hemolytic Anemia
Wilma Barcellini, Bruno Fattizzo
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 109
A randomized and double‐blind controlled trial evaluating the safety and efficacy of rituximab for warm auto‐immune hemolytic anemia in adults (the RAIHA study)
Marc Michel, Louis Terriou, Françoise Roudot‐Thoraval, et al.
American Journal of Hematology (2016) Vol. 92, Iss. 1, pp. 23-27
Open Access | Times Cited: 103
How I manage patients with cold agglutinin disease
Sigbjørn Berentsen
British Journal of Haematology (2018) Vol. 181, Iss. 3, pp. 320-330
Open Access | Times Cited: 98
Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial
Ulrich Jäger, Shirley D’Sa, Christian Schörgenhofer, et al.
Blood (2018) Vol. 133, Iss. 9, pp. 893-901
Open Access | Times Cited: 98
Defining autoimmune hemolytic anemia: a systematic review of the terminology used for diagnosis and treatment
Quentin A. Hill, Anita Hill, Sigbjørn Berentsen
Blood Advances (2019) Vol. 3, Iss. 12, pp. 1897-1906
Open Access | Times Cited: 98
How I treat cold agglutinin disease
Sigbjørn Berentsen
Blood (2021) Vol. 137, Iss. 10, pp. 1295-1303
Open Access | Times Cited: 93
How I treat warm autoimmune hemolytic anemia
Wilma Barcellini, Bruno Fattizzo
Blood (2021) Vol. 137, Iss. 10, pp. 1283-1294
Open Access | Times Cited: 92
Evans’ Syndrome: From Diagnosis to Treatment
S. Audia, N. Grienay, Morgane Mounier, et al.
Journal of Clinical Medicine (2020) Vol. 9, Iss. 12, pp. 3851-3851
Open Access | Times Cited: 90
Autoimmune hemolytic anemia: current knowledge and perspectives
Sylwia Sulimiera Michalak, Anna Olewicz‐Gawlik, Joanna Rupa‐Matysek, et al.
Immunity & Ageing (2020) Vol. 17, Iss. 1
Open Access | Times Cited: 88
Page 1 - Next Page

Scroll to top